AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05829083 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Asymmetric nasal cannula - DUET
Description: DUET asymmetric nasal high flow interface that fits best to the patients' nostrils (size: one nostril of the patient should be fully occluded)~Patients will be crossed-over between the 2 interventions
Study NCT05829083 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Asymmetric nasal cannula - DUET
Description: DUET asymmetric nasal high flow interface that fits best to the patients' nostrils (size: one nostril of the patient should be fully occluded)~Patients will be crossed-over between the 2 interventions
Study NCT05829083 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Conventional nasal high flow cannula
Description: Well-established conventional nasal high flow cannula (size: medium)~Patients will be crossed-over between the 2 interventions
Study NCT05829083 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional nasal high flow cannula
Description: Well-established conventional nasal high flow cannula (size: medium)~Patients will be crossed-over between the 2 interventions
Study NCT06199700 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine hydrochloride
Description: Intravenous infusion of Ketamine
Study NCT06060691 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Kaempferol
Description: Kaempferol
Study NCT06503276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib
Description: Orelabrutinib PO will be administered as per the schedule specified in the respective arm
Study NCT05977660 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cumberland ankle instability tool for diagnose to determine ankle instability and its severity
Description: CAIT is a Patient-reported measures of outcome (PROM) and it is very simple, reliable, and valid measurement tool that is used without comparing with the contralateral ankle, which consists of 9 questions and is scored between 0 and 30, developed by Hiller and her colleagues in 2006 to measure the severity of functional ankle instability. Low scores of the participants indicate poor ankle stability, while high scores indicate good ankle stability.
Study NCT06450327 — intervention group
Intervention type: OTHER
Intervention: This is a cross-sectional observational study
Description: There will be no intervention in the study.
Study NCT05873777 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
Description: Each subject receives a single intravenous injection of 18F-FDG and 68Ga-FAP-LM3, and undergo PET/CT imaging within the specified time. A part of participants will undergo additional 68Ga-FAPI-46 PET/CT for comparison.
Study NCT04903015 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: The following sequences of the MRI will be acquired during the inclusion visit:~* 3D T1 gradient echo (GRE): anatomy; registration; cerebral, white matter, and grey matter volumetry; and cortical thickness;~* multiecho 3D T2 GRE: quantitative susceptibility mapping (QSM), iron overload quantification;~* continuous arterial spin labeling (ASL) 3D: cerebral perfusion;~* resting-state fMRI: functional connectivity;~* 64-direction DTI (b=1000 and 2500): alterations in white matter and its microstructure, anatomic connectivity;~* monovoxel spectroscopy of the mesencephalus with short echo time (TE).
Study NCT04903015 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: The following sequences of the MRI will be acquired during the inclusion visit:~* 3D T1 gradient echo (GRE): anatomy; registration; cerebral, white matter, and grey matter volumetry; and cortical thickness;~* multiecho 3D T2 GRE: quantitative susceptibility mapping (QSM), iron overload quantification;~* continuous arterial spin labeling (ASL) 3D: cerebral perfusion;~* resting-state fMRI: functional connectivity;~* 64-direction DTI (b=1000 and 2500): alterations in white matter and its microstructure, anatomic connectivity;~* monovoxel spectroscopy of the mesencephalus with short echo time (TE).
Study NCT06503276 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ultra-low dose radiotherapy
Description: 2 Gy radiotherapy will be administerd twice in the first cycle
Study NCT05005832 — intervention group
Intervention type: OTHER
Intervention: multi day walking
Description: Over the course of 14 days, the pilgrims will cover a distance of about 300 km.
Study NCT05795725 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Artificial Intelligence-assisted Fecal Microbiome Testing
Description: Next-generation sequencing of fecal samples and artificial intelligence analysis of test results
Study NCT05795725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Description: Colonoscopy procedure
Study NCT05765955 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: POLB 001
Description: Investigational Medicinal Product
Study NCT05765955 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo
Study NCT05431309 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Coronary Computed Tomography Angiography
Description: Intervention strategies were selected according to CCTA results
Study NCT05431309 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard Treatment
Description: Traditional cardiovascular disease prevention strategy based on Chinese guideline
Study NCT05619146 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Motor-assisted arms and legs cycling
Description: The participants will complete 60min of active cycling training paradigm, 5 times a week, for 12 weeks. The cycling ergometer will be used to provide motorized assistance during simultaneous arms and legs cycling to the participant while they are seated.
Study NCT05643469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-determination theory-based intervention plus instant messaging
Description: subjects will receive brief interventions using the AWARD model and they will be allowed to select their own quit schedules (quit immediately, or quit progressively) with the ultimate goal of complete cessation. Follow-up booster intervention with WhatsApp/WeChat messages to help them to adhere to their schedules and independent 1-minute videos will be delivered.
Study NCT05643469 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: AWARD model
Description: Subjects will receive a brief intervention using the AWARD model and all of them will advise to quit immediately. Only general health advice via WhatsApp/WeChat will be delivered.
Study NCT05506046 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduced nicotine message exposure
Description: Participants will be shown two messages about harms of reduced nicotine cigarettes. The two messages will be drawn from a pool of five messages. The messages will communicate that reduced nicotine cigarettes will still have the rest of the harmful chemicals and cause diseases as the regular cigarettes, but they would make it easier to quit.
Study NCT05506046 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified risk message exposure
Description: Participants will be shown two messages about electronic cigarettes as an alternative to regular cigarettes. The two messages will be drawn from a pool of five messages. The messages will communicate that electronic cigarettes are less likely than regular cigarettes to cause severe diseases such as lung cancer.
Study NCT05506046 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined message exposure (reduced nicotine + modified risk)
Description: Participants will be shown two messages, one from the reduced nicotine message set and one modified risk message set.
Study NCT05506046 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control message exposure
Description: Participants will be shown two messages about drinking bottled water. These will be selected from a pool of five message. The messages display specific water products and describe hydration as a healthy activity.
Study NCT05047692 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AdCLD-CoV19-1
Description: Replication deficient adenoviral vector based COVID-19 prevention vaccine containing recombinant gene of SARS-CoV-2 spike protein
Study NCT05496647 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Before the surgical procedure; the Structured Patient Description Form, Fear of Pain Scale, Life Information Follow-up Form, State Anxiety Inventory, and Visual Comparison Scale forms will be filled by the researcher using a face-to-face interview technique with the woman.~During the process; the Preferred video will be watched with Virtual Reality Glasses for approximately 20 minutes during the process, After Daily Gynecological Surgery 1. Measurements; Immediately after the procedure, within the first 10 minutes; Life Information Follow-up Form, Visual Comparison Scale will be filled.~2. Measurements After Daily Gynecological Surgery; At the 1st hour after the procedure, Vital Information Follow-up Form and Visual Comparison Scale will be filled.~3. Measurements After Daily Gynecological Surgery; In the 2nd hour after the procedure; Life Information Follow-up Form, State Anxiety Inventory, Visual Comparison Scale and Satisfaction Evaluation Form will be filled.
Study NCT05496647 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Before the surgical procedure; the Structured Patient Description Form, Fear of Pain Scale, Life Information Follow-up Form, State Anxiety Inventory, and Visual Comparison Scale forms will be filled by the researcher using a face-to-face interview technique with the woman.~During the process; During the procedure, the preferred music for Music Therapy will be played for approximately 20 minutes, After Daily Gynecological Surgery 1. Measurements; Immediately after the procedure, within the first 10 minutes; Life Information Follow-up Form and Visual Comparison Scale will be filled.~2. Measurements After Daily Gynecological Surgery; In the 1st hour after the procedure, the Vital Information Follow-up Form and Visual Comparison Scale will be filled.~3. Measurements After Daily Gynecological Surgery; In the 2nd hour after the procedure; Life Information Follow-up Form, State Anxiety Inventory, Visual Comparison Scale, and Satisfaction Evaluation Form will be filled.
Study NCT05496647 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stress Ball Application
Description: Before the surgical procedure; the Structured Patient Description Form, Fear of Pain Scale, Life Information Follow-up Form, State Anxiety Inventory, and Visual Comparison Scale forms will be filled by the researcher using a face-to-face interview technique with the woman.~During the process; the Stress ball will be played for approximately 20 minutes during the process.~After Daily Gynecological Surgery 1. Measurements; Immediately after the procedure, within the first 10 minutes; Life Information Follow-up Form and Visual Comparison Scale will be filled.~2. Measurements After Daily Gynecological Surgery; In the 1st hour after the procedure, the Vital Information Follow-up Form and Visual Comparison Scale will be filled.~3. Measurements After Daily Gynecological Surgery; In the 2nd hour after the procedure; Life Information Follow-up Form, State Anxiety Inventory, Visual Comparison Scale, and Satisfaction Evaluation Form will be filled.
Study NCT05496647 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Before the surgical procedure; the Structured Patient Description Form, Fear of Pain Scale, Life Information Follow-up Form, State Anxiety Inventory, and Visual Comparison Scale forms will be filled by the researcher using a face-to-face interview technique with the woman.~During the process; Women in the control group will not undergo any intervention other than routine surgery.~After Daily Gynecological Surgery 1. Measurements; Immediately after the procedure, within the first 10 minutes; Life Information Follow-up Form and Visual Comparison Scale will be filled.~2. Measurements After Daily Gynecological Surgery; In the 1st hour after the procedure, the Vital Information Follow-up Form and Visual Comparison Scale will be filled.~3. Measurements After Daily Gynecological Surgery; In the 2nd hour after the procedure, the Life Information Follow-up Form, State Anxiety Inventory, Visual Comparison Scale, and Satisfaction Evaluation Form will be filled.
Study NCT05729360 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GamCoviMab
Description: A total of 30 people will be randomized and receive the study drug (GamCoviMab) in a hospital setting (7 days of hospitalization).
Study NCT05822076 — intervention group
Intervention type: PROCEDURE
Intervention: Paravertebral block (ropivacaine) left
Description: Paravertebral block at the level of 3rd thoracic intervertebral space on the left side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients
Study NCT05822076 — intervention group
Intervention type: PROCEDURE
Intervention: Paravertebral block (ropivacaine) right
Description: Paravertebral block at the level of 3rd thoracic intervertebral space on the right side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients
Study NCT06178211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunotherapy: Adebrelimab
Description: Adebrelimab 1200mg Q3W
Study NCT06178211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chemotherapy: carboplatin plus nab-paclitaxel
Description: carboplatin plus nab-paclitaxel
Study NCT04723927 — intervention group
Intervention type: OTHER
Intervention: Older adults
Description: The data for motor function and gait pattern analysis was obtained.
Study NCT05188261 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IW-3300
Description: A single dose of IW-3300 administered rectally (as a low-volume \[20 mL\] enema) following a fast of at least 6 hours.
Study NCT05188261 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A single dose of placebo administered rectally (as a low-volume \[20 mL\] enema) following a fast of at least 6 hours.
Study NCT06139783 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise and dietary recommendations
Description: Online physical exercise program and online nutritional assessment with personalized health and dietary recommendations
Study NCT06576947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Participants receive virtual reality treatment, 8 weeks of treatment/ 2 times a week
Study NCT06576947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromodulation of the tibialis posterior nerve
Description: Participants receive neuromodulation of the tibialis posterior nerve8 weeks of treatment/ 2 times a week/ 30 minutes
Study NCT06576947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Description: Participants receive pelvic floor muscle training 5 times a day for 9 weeks
Study NCT06574074 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Gain-Life (Give informAtIoN to transform Life)
Description: The Gain Life intervention comprises four components: (i) information about depression, (ii) awareness of available services, (iii) stigma reduction through dispelling myths and facts about depression, and (iv) a life transformation story. The first module aims to raise awareness about depression, with a particular focus on its causes, manifestations, and the potential negative consequences of untreated depression. The second component includes the types of services offered, costs, distance to service providers, and operating hours. The third component address stigma and misconceptions surrounding depression by addressing the root causes of stigma, dispelling myths, and providing accurate information about depression. The final module of the Gain Life intervention features recovery stories of individuals who have overcome depression. This module includes two 8-minute video stories of individuals who successfully recovered from depression.
Study NCT06413108 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TB31F
Description: transmission-blocking monoclonal antibody TB31F
Study NCT06413108 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: normal saline as control (placebo)
Study NCT06049563 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnostic MRI
Description: MRI scan of the upper abdomen performed with the low-field 0.4T MRI system.
Study NCT06509087 — intervention group
Intervention type: PROCEDURE
Intervention: Transarterial microembolization (TAME)
Description: TAME primarily targets abnormal neovascularization for embolization in chronic shoulder or knee joint pain.
Study NCT06451172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASO
Description: Anticipated 20 Participants will receive a single group administered via eye drops in the study eye.
Study NCT06532214 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: International Study Group for Liver Surgery (ISGLS)
Description: According to the ISGLS criteria, the patient was judged to have liver failure and further analysis
Study NCT05314439 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ION904
Description: ION904 will be administered by SC injection.
Study NCT05314439 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered by SC injection.
Study NCT04728295 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exablate 4000
Description: Exablate Pallidothalamic Tractotomy
Study NCT05974527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sublingual film containing dexmedetomidine (BXCL501)
Description: Enrolled participants will receive an initial dose of BXCL501 180mcg. Following the FDA dosing suggestions, participants with mild or moderate hepatic impairment (Child-Pugh Class A or B) will receive a reduced initial dose of 120mcg and participants with severe hepatic impairment (Child-Pugh Class C) will receive a reduced initial dose of 90mcg. Geriatric patients (≥ 65 years old) will receive a reduced initial dose of 120mcg.
Study NCT05123508 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 2940nm and BBL treatment
Description: 2940nm and BBL treatment
Study NCT05123508 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-treatment side (Control)
Description: No treatment
Study NCT05981443 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dermabond
Description: Use of Dermabond to close surgical incisions instead of non-absorbable sutures
Study NCT05981443 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-Absorbable Sutures
Description: Use of conventional non-absorbable sutures to close surgical incisions
Study NCT05881564 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: blood use for priming cardiopulmonary bypass circuit
Description: one arm will have the cardiopulmonary bypass circuit primed with blood
Study NCT05881564 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: clear prime for cardiopulmonary bypass
Description: this arm will not have bypass circuit primed with blood
Study NCT04582539 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB000928
Description: INCB000928 will be administered once daily.
Study NCT06574152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBM treatment
Description: Immediately after the apical microsurgery, PBM therapy will be performed using a 660 nm diode laser (SiroLaser Advance Plus, Dentsply Sirona Inc, Charlotte, North Carolina, USA), with an 8 mm tip diameter . The laser tip will be placed following the outline of the incision flap in a contact mode . The power output of the laser will be 50 milliwatt (mW) and verified by a Power Meter (PM600 Power/Energy meter, Molectron Detector Inc, Portland, OR, USA). Each site will be irradiated for 25 s with an energy density of 10 J/cm2
Study NCT06574152 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: PBM sham treatment
Description: Immediately after the apical microsurgery, sham therapy will be performed without activating the laser.
Study NCT06574152 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: EMS
Description: Patients will be anesthetized. All surgeries will be performed using a surgical microscope. After reflection of a mucoperiosteal flap, osteotomies will be performed to access the root apices and apical lesions. Root apices will be resected at 3 mm, and the pathological tissue curetted out. Next, root-end preparations will be made with ultrasonic tips and filled with calcium silicate-based materials. Methylene blue dye will be used for inspection after root-end resection before the root-end preparation and filling. After cleaning the osseous crypt, the wound margins will be reapproximated with 5-0 single interrupted sutures. A gauze will be placed for 30 minutes for wound compression. Sutures will be removed seven days postoperatively
Study NCT06574152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EMS
Description: Patients will be anesthetized. All surgeries will be performed using a surgical microscope. After reflection of a mucoperiosteal flap, osteotomies will be performed to access the root apices and apical lesions. Root apices will be resected at 3 mm, and the pathological tissue curetted out. Next, root-end preparations will be made with ultrasonic tips and filled with calcium silicate-based materials. Methylene blue dye will be used for inspection after root-end resection before the root-end preparation and filling. After cleaning the osseous crypt, the wound margins will be reapproximated with 5-0 single interrupted sutures. A gauze will be placed for 30 minutes for wound compression. Sutures will be removed seven days postoperatively